Company: GVH
Filing Date: 2025-10-01
Form Type: F-3
Source: 0001213900-25-094769
Chunk: 2

Company: Globavend Holdings Ltd
Filing Date: 2025-10-01
Form: F-3
Chunk 2
---
, subscription rights, purchase contracts, and units.

This prospectus provides a general
description of the securities we may offer. Each time we sell securities pursuant to this prospectus, we will provide specific information
about the offering and the specific terms of the securities offered in one or more supplements to this prospectus. We may also authorize
one or more free writing prospectuses to be provided to you in connection with these offerings. The prospectus supplement and any related
free writing prospectus may add, update, or change information in this prospectus. You should read carefully this prospectus, the applicable
prospectus supplement, and any related free writing prospectus, as well as the documents incorporated or deemed to be incorporated by
reference into this prospectus and any related free writing prospectus together with additional information described below under “Where You Can Find Additional Information” and “Incorporation of Certain Information by Reference”, before you
invest in any of our securities. This prospectus may not be used to offer or sell any securities unless accompanied by the applicable
prospectus supplement.

Our Ordinary Shares are listed
on the Nasdaq Capital Market, or “Nasdaq,” under the symbol “GVH.” On September 30, 2025, the last reported sale
price of our Ordinary Shares on Nasdaq was $4.59 per share. The aggregate market value of our issued and outstanding Ordinary Shares held
by non-affiliates, or public float, as of September 30, 2025, was approximately $8,725,201, which was calculated based on 1,468,889 Ordinary
Shares held by non-affiliates and the price of $5.94 per share, which was the closing price of our Ordinary Shares on Nasdaq on August
29, 2025. Pursuant to General Instruction I.B.5 of Form F-3, in no event will we sell our securities registered on this registration statement
of which any prospectus supplement forms a part in a public primary offering with a value exceeding more than one-third of our outstanding
voting and nonvoting common equity held by non-affiliates (the “Public Float”) in any 12-month period so long as our Public
Float remains below $75 million. During the 12 calendar months prior to and including the date of this prospectus, we have not offered
or sold any securities pursuant to General Instruction I.B.5 of Form F-3.

Investing in our Securities is highly